{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:38:31Z","timestamp":1792787911276,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073625\uff0c82373655"],"award-info":[{"award-number":["82073625\uff0c82373655"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guangdong Medical Research Foundation Projects","award":["C2023054"],"award-info":[{"award-number":["C2023054"]}]},{"name":"Planned Science and Technology Project of Guangdong Province","award":["2019B020230002"],"award-info":[{"award-number":["2019B020230002"]}]},{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major 387 Project","award":["2023ZD0501003"],"award-info":[{"award-number":["2023ZD0501003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14539-5","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T03:18:44Z","timestamp":1751339924000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Diagnostic performance of EBV DNA load testing for nasopharyngeal carcinoma in nasopharyngeal swab outperforms the approach in other specimens"],"prefix":"10.1186","volume":"25","author":[{"given":"Xue-Qi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Feng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Cong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang-Hang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke-Na","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang-Ning","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Cong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Ping","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Nan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-Mei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"5","key":"14539_CR1","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.ijrobp.2015.11.047","volume":"94","author":"KO Lam","year":"2016","unstructured":"Lam KO, Lee AW, Choi CW, Sze HC, Zietman AL, Hopkins KI, Rosenblatt E. Global pattern of nasopharyngeal cancer: correlation of outcome with access to radiation therapy. Int J Radiat Oncol Biol Phys. 2016;94(5):1106\u201312.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"14539_CR2","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1002\/cac2.12100","volume":"40","author":"R Tan","year":"2020","unstructured":"Tan R, Phua SKA, Soong YL, Oon LLE, Chan KS, Lucky SS, Mong J, Tan MH, Lim CM. Clinical utility of Epstein-Barr virus DNA and other liquid biopsy markers in nasopharyngeal carcinoma. Cancer Commun. 2020;40(11):564\u201385.","journal-title":"Cancer Commun"},{"issue":"4","key":"14539_CR3","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1093\/jnci\/djad012","volume":"115","author":"WKJ Lam","year":"2023","unstructured":"Lam WKJ, King AD, Miller JA, Liu Z, Yu KJ, Chua MLK, Ma BBY, Chen MY, Pinsky BA, Lou P-J, et al. Recommendations for Epstein-Barr virus-based screening for nasopharyngeal cancer in high- and intermediate-risk regions. J Natl Cancer Inst. 2023;115(4):355\u201364.","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"14539_CR4","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41571-021-00524-x","volume":"18","author":"KCW Wong","year":"2021","unstructured":"Wong KCW, Hui EP, Lo K-W, Lam WKJ, Johnson D, Li L, Tao Q, Chan KCA, To K-F, King AD, et al. Nasopharyngeal carcinoma: an evolving paradigm. Nat Rev Clin Oncol. 2021;18(11):679\u201395.","journal-title":"Nat Rev Clin Oncol"},{"issue":"10192","key":"14539_CR5","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","volume":"394","author":"Y-P Chen","year":"2019","unstructured":"Chen Y-P, Chan ATC, Le Q-T, Blanchard P, Sun Y, Ma J. Nasopharyngeal carcinoma. Lancet. 2019;394(10192):64\u201380.","journal-title":"Lancet"},{"issue":"2","key":"14539_CR6","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/ijc.26380","volume":"131","author":"Y Liu","year":"2012","unstructured":"Liu Y, Huang Q, Liu W, Liu Q, Jia W, Chang E, Chen F, Liu Z, Guo X, Mo H, et al. Establishment of VCA and EBNA1 IgA-based combination by enzyme-linked immunosorbent assay as preferred screening method for nasopharyngeal carcinoma: a two-stage design with a preliminary performance study and a mass screening in southern China. Int J Cancer. 2012;131(2):406\u201316.","journal-title":"Int J Cancer"},{"issue":"3","key":"14539_CR7","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1093\/aje\/kws404","volume":"177","author":"Z Liu","year":"2013","unstructured":"Liu Z, Ji M-F, Huang Q-H, Fang F, Liu Q, Jia W-H, Guo X, Xie S-H, Chen F, Liu Y, et al. Two Epstein-Barr virus-related serologic antibody tests in nasopharyngeal carcinoma screening: results from the initial phase of a cluster randomized controlled trial in Southern China. Am J Epidemiol. 2013;177(3):242\u201350.","journal-title":"Am J Epidemiol"},{"issue":"4","key":"14539_CR8","doi-asserted-by":"publisher","first-page":"e19100","DOI":"10.1371\/journal.pone.0019100","volume":"6","author":"S-M Cao","year":"2011","unstructured":"Cao S-M, Liu Z, Jia W-H, Huang Q-H, Liu Q, Guo X, Huang T-B, Ye W, Hong M-H. Fluctuations of epstein-barr virus serological antibodies and risk for nasopharyngeal carcinoma: a prospective screening study with a 20-year follow-up. PLoS ONE. 2011;6(4):e19100.","journal-title":"PLoS ONE"},{"issue":"6","key":"14539_CR9","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1093\/annonc\/mdz106","volume":"30","author":"AD King","year":"2019","unstructured":"King AD, Woo JKS, Ai QY, Chan JSM, Lam WKJ, Tse IOL, Bhatia KS, Zee BCY, Hui EP, Ma BBY, et al. Complementary roles of MRI and endoscopic examination in the early detection of nasopharyngeal carcinoma. Ann Oncol. 2019;30(6):977\u201382.","journal-title":"Ann Oncol"},{"issue":"7","key":"14539_CR10","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1093\/jnci\/djaa198","volume":"113","author":"JA Miller","year":"2021","unstructured":"Miller JA, Le Q-T, Pinsky BA, Wang H. Cost-effectiveness of nasopharyngeal carcinoma screening with Epstein-Barr virus polymerase chain reaction or serology in high-incidence populations worldwide. J Natl Cancer Inst. 2021;113(7):852\u201362.","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"14539_CR11","first-page":"1188","volume":"59","author":"YM Lo","year":"1999","unstructured":"Lo YM, Chan LY, Lo KW, Leung SF, Zhang J, Chan AT, Lee JC, Hjelm NM, Johnson PJ, Huang DP. Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Res. 1999;59(6):1188\u201391.","journal-title":"Cancer Res"},{"issue":"6","key":"14539_CR12","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1007\/s00405-015-3620-y","volume":"273","author":"SD Stoker","year":"2016","unstructured":"Stoker SD, Wildeman MA, Novalic Z, Fles R, van der Noort V, de Bree R, Braunius WW, van den Broek GB, Kreike B, Kross KW, et al. Can Epstein-Barr virus DNA load in nasopharyngeal brushings or whole blood predict recurrent nasopharyngeal carcinoma in a non-endemic region? A prospective nationwide study of the Dutch Head and Neck Oncology Cooperative Group. Eur Arch Otorhinolaryngol. 2016;273(6):1557\u201367.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"14539_CR13","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ejca.2021.05.022","volume":"153","author":"AWM Lee","year":"2021","unstructured":"Lee AWM, Lee VHF, Ng W-T, Strojan P, Saba NF, Rinaldo A, Willems SM, Rodrigo JP, Forastiere AA, Ferlito A. A systematic review and recommendations on the use of plasma EBV DNA for nasopharyngeal carcinoma. Eur J Cancer. 2021;153:109\u201322.","journal-title":"Eur J Cancer"},{"key":"14539_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.1597","author":"W-Q Xue","year":"2018","unstructured":"Xue W-Q, He Y-Q, Liao X-Y, Li F-F, Xu Y-F, Xu F-H, Li X-Z, Feng Q-S, Chen L-Z, Cao S-M, et al. Decreased oral Epstein-Barr virus DNA loads in patients with nasopharyngeal carcinoma in Southern China: a case-control and a family-based study. Cancer Med. 2018;7(7):3453\u201364. https:\/\/doi.org\/10.1002\/cam4.1597.","journal-title":"Cancer Med"},{"issue":"1","key":"14539_CR15","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1186\/s12885-021-08408-0","volume":"21","author":"W-J Chen","year":"2021","unstructured":"Chen W-J, Xu W-N, Wang H-Y, Chen X-X, Li X-Q, Xie S-H, Lin D-F, Cao S-M. Plasma Epstein-Barr virus DNA and risk of nasopharyngeal carcinoma in a prospective seropositive population. BMC Cancer. 2021;21(1):651.","journal-title":"BMC Cancer"},{"issue":"9","key":"14539_CR16","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/cncr.28564","volume":"120","author":"MF Ji","year":"2014","unstructured":"Ji MF, Huang QH, Yu X, Liu Z, Li X, Zhang LF, Wang P, Xie SH, Rao HL, Fang F, et al. Evaluation of plasma Epstein-Barr virus DNA load to distinguish nasopharyngeal carcinoma patients from healthy high-risk populations in Southern China. Cancer. 2014;120(9):1353\u201360.","journal-title":"Cancer"},{"key":"14539_CR17","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2023-0510","author":"Z-C Wu","year":"2023","unstructured":"Wu Z-C, Lin K-N, Li X-Q, Ye X, Chen H, Tao J, Zhou H-N, Chen W-J, Lin D-F, Xie S-H, et al. Development and analytical validation of a novel nasopharynx swab-based Epstein-Barr virus C promoter methylation quantitative assay for nasopharyngeal carcinoma detection. Clin Chem Lab Med. 2023. https:\/\/doi.org\/10.1515\/cclm-2023-0510.","journal-title":"Clin Chem Lab Med"},{"issue":"2","key":"14539_CR18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3322\/caac.21388","volume":"67","author":"MB Amin","year":"2017","unstructured":"Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK, Meyer L, Gress DM, Byrd DR, Winchester DP. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more \u201cpersonalized\u201d approach to cancer staging. CA Cancer J Clin. 2017;67(2):93\u20139.","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"14539_CR19","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1093\/clinchem\/hvac032","volume":"68","author":"GH Chen","year":"2022","unstructured":"Chen GH, Liu Z, Yu KJ, Coghill AE, Chen XX, Xie SH, Lin DF, Huang QH, Lu YQ, Ling W, et al. Utility of Epstein-Barr virus DNA in nasopharynx swabs as a reflex test to triage seropositive individuals in nasopharyngeal carcinoma screening programs. Clin Chem. 2022;68(7):953\u201362.","journal-title":"Clin Chem"},{"issue":"6","key":"14539_CR20","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1056\/NEJMoa1701717","volume":"377","author":"KCA Chan","year":"2017","unstructured":"Chan KCA, Woo JKS, King A, Zee BCY, Lam WKJ, Chan SL, Chu SWI, Mak C, Tse IOL, Leung SYM, et al. Analysis of plasma Epstein-Barr virus DNA to screen for nasopharyngeal cancer. N Engl J Med. 2017;377(6):513\u201322.","journal-title":"N Engl J Med"},{"issue":"26","key":"14539_CR21","doi-asserted-by":"publisher","first-page":"4257","DOI":"10.1200\/JCO.22.01979","volume":"41","author":"P-J Lou","year":"2023","unstructured":"Lou P-J, Jacky Lam WK, Hsu W-L, Pfeiffer RM, Yu KJ, Chan CML, Lee VCT, Chen T-C, Terng S-D, Tsou Y-A, et al. Performance and operational feasibility of Epstein-Barr virus-based screening for detection of nasopharyngeal carcinoma: direct comparison of two alternative approaches. J Clin Oncol. 2023;41(26):4257\u201366.","journal-title":"J Clin Oncol"},{"issue":"20","key":"14539_CR22","doi-asserted-by":"publisher","first-page":"3652","DOI":"10.1016\/j.cell.2022.08.026","volume":"185","author":"B Damania","year":"2022","unstructured":"Damania B, Kenney SC, Raab-Traub N. Epstein-Barr virus: biology and clinical disease. Cell. 2022;185(20):3652\u201370.","journal-title":"Cell"},{"key":"14539_CR23","doi-asserted-by":"publisher","first-page":"587380","DOI":"10.3389\/fimmu.2020.587380","volume":"11","author":"G Houen","year":"2020","unstructured":"Houen G, Trier NH. Epstein-Barr virus and systemic autoimmune diseases. Front Immunol. 2020;11:587380.","journal-title":"Front Immunol"},{"issue":"12","key":"14539_CR24","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1002\/jmv.26198","volume":"92","author":"M-Q Zheng","year":"2020","unstructured":"Zheng M-Q, Wang T-M, Liao Y, Xue W-Q, He Y-Q, Wu Z-Y, Yang D-W, Li D-H, Deng C-M, Jia Y-J, et al. Nasopharyngeal Epstein-Barr virus DNA loads in high-risk nasopharyngeal carcinoma families: familial aggregation and host heritability. J Med Virol. 2020;92(12):3717\u201325.","journal-title":"J Med Virol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14539-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14539-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14539-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T03:18:45Z","timestamp":1751339925000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14539-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14539"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14539-5","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"9 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided voluntary informed consents. This study was adhered to the Declaration of Helsinki and approved by the Human Ethics Committee of the Sun Yat-Sen University Cancer Center (GZR2020-325).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1126"}}